EAU 2013 - Programme Book - YouMed

Saturday
90 Programme Book
82 Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for aged
patients with advanced upper-tract urothelial cancer
T. Yoneyama, Y. Suzuki, N. Sugiyama, Y. Tobisawa, T. Yoneyama, A. Okamoto, H. Yamamoto, A. Imai,
S. Hatakeyama, K. Mori, Y. Hashimoto, T. Koie, C. Ohyama (Hirosaki, Japan)
83 Long-term efficacy and safety outcomes of the modified (simplified) combination of methotrexate,
vinblastine, doxorubicin, and cisplatin (MVAC) as front-line therapy for unresectable or metastatic
urothelial cancer (UC)
A. Necchi, L. Mariani, P. Giannatempo, D. Raggi, E. Farè, G. Pizzocaro, L. Piva, D. Biasoni, T. Torelli,
M. Catanzaro, S. Stagni, A. Milani, A. Gianni, F. De Braud, N. Nicolai, R. Salvioni (Milan, Italy)
84 Comparative effectiveness of gemcitabine and paclitaxel versus best supportive care in metastatic
urothelial carcinoma who have previously been treated with platinum based chemotherapy
S. Kudou, H.Z. Zakouji, M.T. Takeda (Chuo Yamanashi, Japan)
85 Management of local recurrences in the irradiated bladder: A systematic review
N. Sapre, P. Anderson, F.F. Foroudi (Melbourne, Australia)